Supreme Court to hear “pay-for-delay” drug case

Keith Hylton, School of Law

The Supreme Court agreed on Friday to decide whether brand-name drug companies may pay money to generic drug rivals to keep their lower-priced products off the market, a practice estimated to cost consumers and the government billions of dollars each year…

View article